Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tycoon Group HoldingsHKSE:03390 +0.88%62 EBITDA Margin % is 5.69% as of Dec. 2025, which is 15% below its 10-year median of 6.72. GuruFocus rates HKSE:03390 with a GF Score™ of 62/100 and a GF Value™ of HK$3.60 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Tycoon Group Holdings ranks worse than 68.17% on this metric.
Tycoon Group Holdings (HKSE:03390) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tycoon Group Holdings EBITDA Margin % Related Terms
Tycoon Group Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Tycoon Group Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tycoon Group Holdings EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Tycoon Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tycoon Group Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tycoon Group Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tycoon Group Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tycoon Group Holdings (HKSE:03390) has a EBITDA Margin % of 5.69% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tycoon Group Holdings and its competitors. This is 15% below median its historical median of 6.72. According to the industry distribution chart, Tycoon Group Holdings ranks #452 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 68.2%.
Is Tycoon Group Holdings' EBITDA Margin % too high?
Tycoon Group Holdings' current EBITDA Margin % of 5.69% is 15% below median its 10-year median of 6.72. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. Tycoon Group Holdings' value of 5.69% is 44.4% below this industry median. Based on the distribution chart, Tycoon Group Holdings ranks #452 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tycoon Group Holdings has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tycoon Group Holdings' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Tycoon Group Holdings ranks #452 out of 663 companies for EBITDA Margin %. This places Tycoon Group Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.23. Tycoon Group Holdings' value of 5.69% is 44.4% below this benchmark. While the company's 10-year median is 6.72 vs. the industry median of 10.23, Tycoon Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tycoon Group Holdings's current EBITDA Margin % of 5.69% is 44.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tycoon Group Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tycoon Group Holdings's current EBITDA Margin % is 5.69%, which is 15% below median its own 10-year median of 6.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tycoon Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Tycoon Group Holdings (HKSE:03390) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$3.60, compared to a current price of HK$0.23 — trading 93.6% below its estimated fair value. The current EBITDA Margin % is 5.69%, which is 15% below median its 10-year median of 6.72 and 44.4% below the Healthcare Providers & Services industry median of 10.23. Tycoon Group Holdings' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tycoon Group Holdings (HKSE:03390), the current EBITDA Margin % is 5.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tycoon Group Holdings (HKSE:03390) Overvalued in 2026?
Based on GuruFocus' analysis, Tycoon Group Holdings stock appears to be undervalued.
The current stock price of HK$0.23 is trading 93.6% below its estimated GF Value™ of HK$3.60.
GuruFocus considers Tycoon Group Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:03390:
EBITDA Margin %: 5.69% (15% below median its 10-year median of 6.72)
GF Value™: HK$3.60 vs. price of HK$0.23 (93.6% below fair value)
Industry Position: 44.4% below the Healthcare Providers & Services median (#452 of 663)
No single metric tells the full story. See the HKSE:03390 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tycoon Group Holdings Ltd and its subsidiaries are principally engaged in the distribution and retail of health and well-being related products. It provides omnichannel brand agency, promotion and marketing, management, distribution, and sales services for PCM, health supplements, skincare, personal care, and other healthcare products. The company operates in three segments: the Distribution segment, which includes the operation of distributing products to chain retailers, non-chain retailers, and traders; the E-Commerce segment, which includes the operation of online stores and distribution to e-commerce customers; and the retail store segment, which represents the operation of Hong Ning Hong Limited. The company derived the maximum revenue from the Distribution segment.
62GF Score
Get the complete analysis for HKSE:03390
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03390 has been successfully added to your 
